Product
Recombinant Anti-VEGF Humanized Monoclonal Antibody Ophthalmic Injection
1 clinical trial
1 indication
Indication
Age-related Macular DegenerationClinical trial
A Phase I/II, Single-arm, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of HLX04-O Administered by Intravitreal Injection in Subjects With Wet Age Related Macular Degeneration (wAMD)Status: Completed, Estimated PCD: 2022-07-07